Coeptis Announces Approval of Z Squared Inc.'s Nasdaq Listing Application - Coeptis Therapeutics ( NASDAQ:
~ Approval Marks Satisfaction of Key Closing Condition in Pending Merger ~ The transaction remains subject to satisfaction of any remaining customary closing conditions, and there can be no assurance that such conditions will be satisfied. The transaction is expected to close in Q2 2026.
https://www.benzinga.com/pressreleases/26/04/g51685024/coeptis-announces-approval-of-z-squared-inc-s-nasdaq-listing-application